Herpes simplex virus (HSV) virions contain at least two regulatory proteins that modulate gene expression in infected cells: the transcriptional activator VP16 and the virion host shutoff protein vhs. VP16 stimulates transcription of the HSV immediate-early genes, and vhs suppresses host protein synthesis and induces accelerated turnover of cellular and viral mRNAs. We report here that vhs binds directly to VP16: vhs and VP16 were coprecipitated from infected cells by an anti-vhs antiserum, and vhs and VP16 protein A fusions each bound intact versions of the other protein in a solid-phase capture assay. In addition, vhs and VP16 interacted in the two-hybrid activator system when coexpressed in Saccharomyces cerevisiae. vhs residues 238 to 344 were sufficient for the interaction, and the VP16 acidic transcriptional activation domain was not required. vhs blocked the ability of VP16 to enter a multiprotein complex on an immediate-early TAATGARATTC consensus sequence, indicating that vhs interacts with one or more regions of VP16 required for promoter recognition. We suggest that this interaction may play a structural role in the assembly of HSV virions and modulate the activity of vhs during infection.
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Herpes simplex virus (HSV) is a large enveloped DNA virus that replicates in the nuclei of mammalian cells. HSV executes a complex genetic program following infection: cellular gene expression is strongly suppressed (12) , and three classes of viral genes-immediate-early (IE), early, and late-are sequentially activated in a defined temporal sequence (25, 60) . This regulatory cascade is driven by viral proteins and encompasses a variety of controls at the transcriptional and posttranscriptional levels. HSV-infected cells, therefore, provide a favorable system to dissect the mechanisms whereby a small number of regulatory proteins collaborate to rapidly reprogram the host cell machinery to express a new set of polymerase II-transcribed genes.
HSV differs from many other nuclear DNA viruses in that some of its regulatory polypeptides are delivered into host cells by the infecting virus particle. These proteins are, therefore, strategically poised to influence the earliest events of the viral life cycle. Prominent among these virion-associated regulators is VP16, an abundant structural protein that plays a critical role in activating transcription of the five IE genes (3, 7) (reviewed in references 22 and 58) . VP16 (also known as Vmw65, a-TIF, and ICP25) is located in the tegument (the space between the envelope and the nucleocapsid) of the HSV virion; as such, it is presumably delivered into cells following fusion of the virion envelope with the host cell plasma membrane. VP16 bears an exceptionally strong acidic transcriptional activation domain (51, 59) and is targeted to DNA through the TAATGARATTC consensus sequence that is found in each of the HSV IE control regions (6, 20, 29, 36, 46) . VP16 has only a low affinity for TAATGARATTC (31) but forms a high-affinity complex through association with cellular factors including Octl and HCF (also known as Cl, VCAF1, and CFF) (4, 21, 27, 28, 30-32, 37, 43, 47, 55, 65, 66) . As such, VP16 has provided a paradigm for the role of protein-protein interactions in promoter recognition in eukaryotic cells. The functional significance of VP16-induced transactivation for the HSV lytic cycle is illustrated by the phenotype of a viral mutant that expresses a transactivation-deficient form of the protein: the mutant is viable but displays an increased particle-to-PFU ratio and reduced IE gene expression at low multiplicities of infection (2) . At higher multiplicities, infection proceeds relatively normally. These data imply that transactivation by VP16 serves to facilitate the onset of IE transcription when cells are infected with a small number of HSV particles, a condition that probably corresponds to the normal situation in the intact human host. VP16 also appears to serve an essential structural role in the assembly of mature HSV particles: it is one of the most abundant HSV virion proteins, and a temperaturesensitive mutation in VP16 blocks virion assembly at the nonpermissive temperature (1) . In agreement with these observations, a complete deletion of the VP16 gene is lethal, and the mutant virus can be propagated only in cells that provide VP16 in trans (61) .
HSV virions also contain one or more proteins that serve to suppress host protein synthesis and trigger accelerated turnover of preexisting cellular mRNAs (12, 13, 16, 18, 41, 42, 52) .
A substantial body of evidence indicates that these processes are intimately linked and require the product of the vhs (virion-induced host shutoff) locus (gene UL41). Thus, a viable HSV type 1 (HSV-1) mutant, vhsl, that was initially selected on the basis of its inability to suppress host protein synthesis was subsequently shown to be defective at inducing accelerated turnover of host mRNAs (33, 48, 56) ; marker rescue experiments mapped the vhsl mutation to gene UL41 (34) . The role of UL41 in host shutoff was confirmed by demonstrations that targeted disruptions of the UL41 gene result in a vhs-deficient phenotype (15, 54) . HSV mRNAs are also at least partially susceptible to vhs-induced attack (14, 17, 33, 44, 45) . However, one or more newly synthesized viral proteins apparently dampen the vhs activity of the infecting virion, thereby allow-ing the accumulation of viral mRNAs after host mRNAs have been degraded (14, 15, 17) . The vhs gene encodes a 58-kDa phosphoprotein that accumulates late during infection and is packaged into the virion tegument (38, 53) . The vhs protein is not required for virion assembly (54) and is much less abundant than VP16 (38) .
We searched for HSV proteins that bind to the vhs gene product as one approach to identifying protein-protein interactions that play a role in the assembly of vhs into virions and/or the regulation of vhs activity during infection. These experiments revealed that vhs forms a specific complex with VP16. vhs residues 238 to 344 were sufficient for the interaction, and the VP16 acidic transcriptional activation domain was not required. vhs blocked the ability of VP16 to enter a multiprotein complex on the TAATGARATTC element, indicating that vhs interacts with one or more of the regions on VP16 required for promoter recognition. We suggest that the vhs-VP16 interaction may play a structural role in virion assembly and modulate the activity of vhs during infection.
MATERIALS AND METHODS
Virus and cells. HSV-1 strain KOS PAAr5 (23) and vhsA (54) (8) after appropriate modification of the ends.
Purification of protein A fusions. Protein A fusions were purified from induced cultures of Escherichia coli N4830-1 by affinity chromatography on immunoglobulin G (IgG) Sepharose (Pharmacia), as previously described (66) . After elution, peak fractions were pooled, dialyzed against 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.9)-100 mM KCl-10% glycerol-0.5 mM dithiothreitol-0.5 mM phenylmethylsulfonyl fluoride, and stored at -70°C.
Preparation of a polyclonal vhs antiserum. Rabbits were injected with 100 ,ug of purified vhs-protein A fusion by using the complete RIBI adjuvant system (Cedarlane) and then boosted at 3-week intervals. Sera were periodically tested for their abilities to immunoprecipitate vhs from infected cell extracts.
Preparation of Vero cell extracts. Vero cells were infected with 10 PFU per cell and then labelled from 2 to 4 h postinfection with 150 1iCi of 35S-methionine (NEN) per ml (1, 100 Ci/mmol). Cells from a 100 mM dish were lysed with 1.0 ml of 150 mM NaCl-1.0% Triton X-100-50 mM Tris HCl (pH 7.2)-1% bovine serum albumin (BSA)-1 mM phenylmethylsulfonyl fluoride-0.3 trypsin inhibitory units of aprotinin per ml, and extracts were centrifuged at 12,000 x g for 20 min. were washed extensively with 150 mM NaCl-1.0% Triton X-100-50 mM Tris HCl (pH 7.2), and bound material was eluted by boiling in 2% sodium dodecyl sulfate (SDS)-20% glycerol-2% 3-mercaptoethanol-250 mM Tris HCl (pH 6.8)-0.25% bromophenol blue. In some experiments, eluted protein was tested for the presence of VP16. In this case, the beads were boiled for 5 min in 2% SDS-2% P-mercaptoethanol-and 250 mM Tris HCl (pH 6.8), and the eluted protein was diluted 10-fold in 150 mM NaCl-1.0% Triton X-100-50 mM Tris HCI (pH 7.2) and then reimmunoprecipitated with the LP1 monoclonal antibody as described above. Proteins were separated by electrophoresis through SDS-polyacrylamide gels (35) crosslinked with N,N'-diallytartardiamide. The gels were then infused with 2,5-diphenyloxazole, dried, and exposed to Kodak XAR 5 film at -70°C.
Preparation of Sepharose beads bearing conjugated fusion proteins. Protein A fusions were coupled to CNBr-activated Sepharose 4B (Pharmacia) as recommended by the manufacturer. The final resin contained 1 to 2 mg of protein per ml of Sepharose beads and was stored in 150 mM NaCl-1.0% Triton X-100-50 mM Tris HCl (pH 7.2) at 4°C.
In vitro transcription and translation. In vitro transcription with SP6 RNA polymerase and in vitro translation in rabbit reticulocyte lysates were done by using kits supplied by Promega Biotec, according to the manufacturer's instructions.
Solid-phase assay for binding of vhs and VP16 to protein A fusions. 35S-methionine-labelled test protein produced in vitro (5 ,ul) was diluted into 150 mM NaCl-1.0% Triton X-100-50 mM Tris HCl (pH 7.2) and mixed end over end with affinity resin (50 p.l) for 3 h. The beads were then washed extensively with the same buffer, and bound material was eluted by boiling in 2% SDS-2% ,-mercaptoethanol-250 mM Tris HCl (pH 6.8).
Mobility shift assays. Protein-DNA mobility shift assays were done as previously described (64) (Fig. 2) . Deletion of vhs residues 24 to 180 (AApa) or truncation at residue 344 (Bam amber) had no effect on binding, while removal of residues 149 to 344 (ASma) or truncation at amino acid 237 (Nru amber) abolished the interaction. Taken in combination, these data suggested that residues located in the central portion of the vhs polypeptide are involved in binding to VP16 (summarized in Fig. 3 ). This hypothesis was confirmed by the finding that small vhs derivatives encompassing residues 179 to 344 (Apa-Sma) or 238 to 344 (Nru-Sma) bound to protein A-VP16 when they were expressed in isolation (Fig. 2) (Fig. 4) . We then examined the ability of a variety of mutant forms of VP16 synthesized in vitro to bind the vhs fusion protein (Fig.  5) Fig. 6 ). We also tested a variety of in-frame VP16 deletions, which in combination spanned much of the polypeptide (Fig. 5B) . In marked contrast to the results with vhs, in which a small contiguous region was sufficient for binding VP16, all of these mutations eliminated binding to vhs. Thus, it would appear that multiple nonoverlapping segments of VP16 are required for the interaction with vhs. It is interesting that the regions critical for vhs interaction defined by these experiments are similar to those required for complex assembly with DNA, Octl, and HCF (see Discussion).
Detection of the vhs-VP16 complex in S. cerevisiae. We used the two-hybrid activator system (8, 19) to test for the formation of the vhs-VP16 complex in S. cerevisiae. This system for detecting protein-protein interactions exploits the fact that the DNA-binding and transcriptional activation domains of GAL4 are inert when coexpressed as separate proteins but can collaborate to form a functional activator if juxtaposed by noncovalent interactions. We linked vhs residues 179 to 344 to the GAL4 DNA-binding domain (vhs/DBD) and various segments of VP16 to the GAL4 activation domain (VP16/AD). The resulting plasmids were then introduced into a yeast strain (PCY2) containing a lacZ reporter gene driven from the GAL4-responsive GALI promoter, and the levels of 3-galactosidase expression were determined ( tion? One possibility is that it serves a structural role in the assembly of the virion tegument. VP16 is essential for virion assembly (1, 61) , and vhs is dispensable (15, 49, 54) ; thus, according to this scenario, VP16 would help to package vhs, not vice versa. This hypothesis is consistent with the observation that a mutant vhs protein lacking residues 149 to 344 (ASma) that cannot bind VP16 (Fig. 2) is not packaged into virus particles (49) . Another possibility is that the interaction modulates the function of either or both vhs and VP16. However, two considerations suggest that vhs probably does not play a major role in regulating transactivation by VP16 in vivo. First, VP16 can activate IE transcription in the absence of vhs (7) , and vhs null mutants do not display the severe growth defects observed with a transactivation-deficient VP16 mutant (unpublished data). Second, VP16 is much more abundant than vhs in both virions and the infected cell, suggesting that vhs does not significantly reduce assembly of VP16 into transactivation complexes in vivo. We consider it more likely that VP16 regulates vhs function, perhaps by sequestering newly synthesized vhs protein into the virion assembly pathway. In this context, it is interesting that a VP16 null mutant (61) initiates infection normally but then undergoes a dramatic decline in viral protein synthesis at intermediate and late times postinfection (60a) . We currently seek to directly determine whether VP16 modulates vhs function during HSV infection.
The minimal VP16-binding domain on vhs defined by our experiments contains sequences that are conserved among the vhs homologs of other alphaherpesviruses, including several invariant Cys and His residues (5); however, it displays no obvious homology to either Octl or HCF. The region is located just downstream of the position of the vhsl point mutation that inactivates vhs function (Thr-214 to Ile [34; also our unpublished data]). It is not yet known whether the VP16-binding region is required for the shutoff activity of vhs. The vhs-VP16 interaction provides a novel reagent for probing the protein-protein and protein-DNA contacts involved in assembly of the VP16 transactivation complex. Our results demonstrate that VP16 residues located between positions 335 and 369 are critical for the interaction with vhs. Recent data indicate that the interval between 360 and 390 plays a major role in the direct interaction with Octl and that residues 360 to 367 and 140 to 230 interact with HCF (24, 55; also our unpublished data); moreover, residues 360 to 367 are exposed on the surface of VP16 (24) . These observations suggest that the binding site for vhs may coincide with, or extensively overlap, the binding site(s) for one or both of these host factors, a possibility that is consistent with the ability of excess vhs to prevent assembly of the transactivation complex. However, the host factors appear to bind VP16 more avidly than vhs does, as evidenced by the finding that vhs has little effect on complex assembly unless it is preincubated with VP16 in the absence of Octl and HCF. This 
